Skip to main content

Gerianne Tringali DiPiano

President and Chief Executive Officer, FemmePharma Global Healthcare, Inc.

Chairman of the Board of Directors, FemmePharma Holding Co, Inc.

Gerianne Tringali DiPiano serves as President and Chief Executive Officer of FemmePharma Global Healthcare, Inc. and is Chairman of the Board of Directors.for FemmePharma Holding Co, Inc. A pharmaceutical industry executive and women’s healthcare expert, Gerianne founded the innovative company in 1996 in response to the industry’s narrow focus on women’s health needs – such as contraception and hormone replacement therapy – but lack of attention to other important women’s diseases and disorders. Her passion for developing new treatment methods for healing has given hope to millions of women. Guided by her vision to provide more effective treatment options for women, FemmePharma Global Healthcare, Inc. is focused on improving women’s health by developing prescription pharmaceuticals that are specifically designed for women across a broad range of therapeutic categories.

With more than 30 years’ experience in the healthcare industry, Gerianne’s background spans many facets of the pharmaceutical industry including pharmaceutical sales, marketing, market and systems planning, medical affairs, new product development, licensing and business development at several multinational companies including Baxter HealthCare/American Hospital Supply Corp., Bristol-Myers Squibb, Sterling-Winthrop and Wyeth.

She has held academic appointments at Saint Joseph’s as Director of the Pharmaceutical MBA program and as an adjunct professor of marketing and has taught courses in strategic and pharmaceutical marketing. Gerianne received her Bachelor of Science degree in biology from Marquette University, MBA from Saint Joseph’s University, and Doctor of Science (HC) from University of the Sciences in Philadelphia.

Currently, she serves on the Board of Trustees for Drexel University and Saint Joseph’s University, the Board of Directors for Living Beyond Breast Cancer, the Corporate Advisory Board of the Society for Gynecologic Investigation, the Editorial Advisory Board of Biotechnology Healthcare, and the Advisory Board for the School of Public Health, Drexel University, and Vice Chair of the Board of Trustees for the Clery Center. She has been a finalist in the Ernst and Young Entrepreneur of the Year for the Greater Philadelphia Region in 2002, 2003 and 2004 and has been recognized in “People to Watch in 2004” by Philadelphia Magazine. She is the 2004 Recipient of the Iris Newman Award sponsored by the Ben Franklin Technology Partners of Southeastern Pennsylvania, was named a Woman of Distinction by the Philadelphia Business Journal in 2006 and was recognized by Governor Rendell as one of Pennsylvania’s 51 Best Women In Business in 2007. She was 2011 Hall of Fame recipient of the HAUB School of Business. PharmaVoice named Gerianne as one of the 100 most inspiring individuals in the United States Pharmaceutical Industry and one of the top 12 entrepreneurs.